In Private Equity Hands, PPD Could Seek More Deals
Executive Summary
Two private equity firms’ agreement to acquire Pharmaceutical Product Development Inc. and take the company private is the latest and largest deal in a recent spate of PE activity among contract research organizations – and perhaps not the last, or even least.
You may also be interested in...
German Biotech MAB Discovery Inks Two Deals For Its Rabbit-Derived Antibody Technology
German antibody services company MAB Discovery – forged by former Roche employees – has had its rabbit antibody-derived technology validated by two collaborative agreements with pharma and biotech companies.
Pfizer Shuffle: Simmons Out, Brandicourt In At Emerging Markets And Established Products Unit
David Simmons, head of established products and emerging markets at Pfizer, has jumped ship to lead global CRO PPD Inc. Olivier Brandicourt, currently head of primary care at the big pharma, will take Simmons’ place.
Pfizer Shuffle: Simmons Out, Brandicourt In At Emerging Markets And Established Products Unit
David Simmons, head of established products and emerging markets at Pfizer, has jumped ship to lead global CRO PPD Inc. Olivier Brandicourt, currently head of primary care at the big pharma, will take Simmons’ place.